Apyx Medical initiated with a Buy at Maxim
Strong upside potential from current levels.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strong upside potential from current levels.
What happened, with direct paths to the underlying reporting
APYX initiated with Buy by Maxim Group; target $6; posted price $2.50.
Target: $6
Posted price: $2.5
Analyst firm: Maxim Group
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.